MXPA03005714A - Sulfamidotienopirimidinas. - Google Patents

Sulfamidotienopirimidinas.

Info

Publication number: MXPA03005714A
Authority: MX; Mexico
Prior art keywords: sulfamidothienopyrimidines
Prior art date: 2000-12-23

Application number

MXPA03005714A

Other languages

English (en)

Inventor

Beier Norbert

Original Assignee

Merck Patent Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-23

Filing date

2001-12-03

Publication date

2003-10-06

2001-12-03 Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh

2003-10-06 Publication of MXPA03005714A publication Critical patent/MXPA03005714A/es

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

MXPA03005714A 2000-12-23 2001-12-03 Sulfamidotienopirimidinas. MXPA03005714A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10064994A DE10064994A1 (de)	2000-12-23	2000-12-23	Sulfamidothienopyrimidine
PCT/EP2001/014102 WO2002051848A2 (de)	2000-12-23	2001-12-03	Sulfamidothienopyrimidine zur verwendung als phosphodiesterase v-hemmer

Publications (1)

Publication Number	Publication Date
MXPA03005714A true MXPA03005714A (es)	2003-10-06

Family

ID=7668967

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA03005714A MXPA03005714A (es)	2000-12-23	2001-12-03	Sulfamidotienopirimidinas.

Country Status (19)

Country	Link
US (1)	US7019013B2 (es)
EP (1)	EP1353927B1 (es)
JP (1)	JP4550361B2 (es)
KR (1)	KR20030062438A (es)
CN (1)	CN1483035A (es)
AR (1)	AR035524A1 (es)
AT (1)	ATE302781T1 (es)
BR (1)	BR0115996A (es)
CA (1)	CA2432582C (es)
CZ (1)	CZ20031815A3 (es)
DE (2)	DE10064994A1 (es)
ES (1)	ES2247007T3 (es)
HU (1)	HUP0302515A3 (es)
MX (1)	MXPA03005714A (es)
PL (1)	PL361733A1 (es)
RU (1)	RU2003122189A (es)
SK (1)	SK8432003A3 (es)
WO (1)	WO2002051848A2 (es)
ZA (1)	ZA200305659B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1401840A4 (en) *	2001-04-30	2007-05-16	Bayer Corp	NEW 4-AMINO-5,6-SUBSTITUTED THIOPHENO 2,3 D \| PYRIMIDINE
ES2328400T3 (es) *	2005-04-21	2009-11-12	Boehringer Ingelheim International Gmbh	Dihidrotienopirimidinas para el tratamiento de enfermedades inflamatorias.
EP1847543A1 (de)	2006-04-19	2007-10-24	Boehringer Ingelheim Pharma GmbH & Co. KG	Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
US8071596B2 (en)	2007-01-12	2011-12-06	Concert Pharmaceuticals, Inc.	Endothelin receptor antagonists
US8080549B2 (en) *	2007-01-12	2011-12-20	Concert Pharmaceuticals, Inc.	Endothelin receptor antagonists
CN101641099A (zh)	2007-01-24	2010-02-03	葛兰素集团有限公司	包含3,5-二氨基-6-(2,3-二氯苯基)-1,2,4-三嗪或r(-)-2,4-二氨基-5-(2,3-二氯苯基)-6-氟甲基嘧啶和nk1的药物组合物
RU2500681C2 (ru)	2007-10-19	2013-12-10	Берингер Ингельхайм Интернациональ Гмбх	Замещенные гетероциклом пиперазинодигидротиенопиримидины
US8486948B2 (en)	2007-10-19	2013-07-16	Boehringer Ingelheim International Gmbh	Piperazinodihydrothienopyrimidine derivatives
SI2215092T1 (sl)	2007-10-19	2012-04-30	Boehringer Ingelheim Int	Substituirani piperidino-dihidrotienopirimidini
EP2595993B1 (en)	2010-07-23	2018-04-18	President and Fellows of Harvard College	Tricyclic proteasome activity enhancing compounds
US20130059866A1 (en)	2011-08-24	2013-03-07	Boehringer Ingelheim International Gmbh	Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
US9802954B2 (en)	2011-08-24	2017-10-31	Boehringer Ingelheim International Gmbh	Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
AU2013202368B2 (en) *	2012-01-25	2016-06-16	Proteostasis Therapeutics, Inc.	Proteasome activity modulating compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19644228A1 (de) *	1996-10-24	1998-04-30	Merck Patent Gmbh	Thienopyrimidine
DE19752952A1 (de) *	1997-11-28	1999-06-02	Merck Patent Gmbh	Thienopyrimidine
DE19819023A1 (de) *	1998-04-29	1999-11-04	Merck Patent Gmbh	Thienopyrimidine
AU3453900A (en) *	1999-03-30	2000-10-23	Nippon Soda Co., Ltd.	Thienopyrimidine compounds and salts thereof and process for the preparation of the same

2000
- 2000-12-23 DE DE10064994A patent/DE10064994A1/de not_active Withdrawn
2001
- 2001-12-03 BR BR0115996-8A patent/BR0115996A/pt not_active Application Discontinuation
- 2001-12-03 HU HU0302515A patent/HUP0302515A3/hu unknown
- 2001-12-03 ES ES01271992T patent/ES2247007T3/es not_active Expired - Lifetime
- 2001-12-03 KR KR10-2003-7008265A patent/KR20030062438A/ko not_active Application Discontinuation
- 2001-12-03 MX MXPA03005714A patent/MXPA03005714A/es not_active Application Discontinuation
- 2001-12-03 RU RU2003122189/04A patent/RU2003122189A/ru not_active Application Discontinuation
- 2001-12-03 CA CA2432582A patent/CA2432582C/en not_active Expired - Fee Related
- 2001-12-03 WO PCT/EP2001/014102 patent/WO2002051848A2/de active IP Right Grant
- 2001-12-03 US US10/451,183 patent/US7019013B2/en not_active Expired - Fee Related
- 2001-12-03 PL PL01361733A patent/PL361733A1/xx unknown
- 2001-12-03 CN CNA018212190A patent/CN1483035A/zh active Pending
- 2001-12-03 DE DE50107230T patent/DE50107230D1/de not_active Expired - Lifetime
- 2001-12-03 SK SK843-2003A patent/SK8432003A3/sk unknown
- 2001-12-03 AT AT01271992T patent/ATE302781T1/de not_active IP Right Cessation
- 2001-12-03 JP JP2002552942A patent/JP4550361B2/ja not_active Expired - Fee Related
- 2001-12-03 CZ CZ20031815A patent/CZ20031815A3/cs unknown
- 2001-12-03 EP EP01271992A patent/EP1353927B1/de not_active Expired - Lifetime
- 2001-12-19 AR ARP010105889A patent/AR035524A1/es not_active Application Discontinuation
2003
- 2003-07-22 ZA ZA200305659A patent/ZA200305659B/en unknown

Also Published As

Publication number	Publication date
RU2003122189A (ru)	2004-12-27
HUP0302515A2 (hu)	2003-11-28
ES2247007T3 (es)	2006-03-01
ATE302781T1 (de)	2005-09-15
DE10064994A1 (de)	2002-07-04
EP1353927B1 (de)	2005-08-24
BR0115996A (pt)	2004-01-06
DE50107230D1 (de)	2005-09-29
PL361733A1 (en)	2004-10-04
CZ20031815A3 (cs)	2003-10-15
KR20030062438A (ko)	2003-07-25
JP4550361B2 (ja)	2010-09-22
AR035524A1 (es)	2004-06-02
CA2432582A1 (en)	2002-07-04
CA2432582C (en)	2011-01-25
SK8432003A3 (en)	2003-10-07
US20040063943A1 (en)	2004-04-01
JP2004516329A (ja)	2004-06-03
US7019013B2 (en)	2006-03-28
WO2002051848A2 (de)	2002-07-04
WO2002051848A3 (de)	2002-10-24
ZA200305659B (en)	2004-08-27
EP1353927A2 (de)	2003-10-22
HUP0302515A3 (en)	2005-06-28
CN1483035A (zh)	2004-03-17

Legal Events

Date	Code	Title	Description
2013-09-30	FA	Abandonment or withdrawal

Publication	Publication Date	Title
MXPA03002410A (es)	2003-06-19	4-amino-quinazolinas.
ZA200205479B (en)	2003-12-31	Novel biarylcarboxamides.
MXPA03005445A (es)	2003-09-10	Barra colectora 12c para aislar los circuitos integrados seleccionados para una comunicacion rapida de barra colectora 12c.
ZA200007669B (en)	2001-07-13	Insert.
ZA200208561B (en)	2003-05-19	Hydraulischer druckverstarker.
EG23262A (en)	2004-10-31	Delta -pyrrolines.
MXPA01009037A (es)	2003-11-18	I-bet.
HK1055426A1 (en)	2004-01-09	Indoloquinazolinones.
MXPA03001591A (es)	2003-09-10	Derivados y analogos de 10-aril-11-h-benzo(b) fluorena para uso medicinal.
MXPA03001877A (es)	2003-06-24	2-guanidin-4-arilquinazolinas.
MXPA03002668A (es)	2003-08-20	Guanidinas de sulfonilo.
ZA200205389B (en)	2003-03-12	Booklet.
MXPA03005714A (es)	2003-10-06	Sulfamidotienopirimidinas.
MXPA03001991A (es)	2003-06-24	Novedosas arilalcano-sulfonamidas.
MXPA03002411A (es)	2003-06-19	4-amino-quinazolinas.
ZA200205482B (en)	2003-12-31	Aminosulfonylbiphenyl derivatives.
MXPA03005494A (es)	2003-10-06	Benzoilpiridazinas.
ZA200206150B (en)	2003-11-03	Aminomethyl-phenyl-cyclohexanone derivatives.
HK1061560A1 (en)	2004-09-24	Triazolo-epothilones.
MXPA01000464A (es)	2003-07-21	Composicion.
MXPA03005217A (es)	2003-09-25	Dispositivos para aplicar un parche.
GB0002612D0 (en)	2000-03-29	C.m.e
GB0006787D0 (en)	2000-05-10	The ecotruck
HK1039800A1 (en)	2002-05-10	Stay.
GB0007510D0 (en)	2000-05-17	D.o.t.t.s